REVOLADE (ELTROMBOPAG) TABLETS, 28 tablet

Official notice

Authority: Belfast Health and Social Care Trust (Central government)

Direct award

Sectors: Medical Devices & Pharma (33) Delivery: Northern Ireland (UKN)

Awarded value£1,000,000published award · exc. VAT

Awarded 17 Jun 2026no call for competition

Awarded to NOVARTIS PHARMACEUTICALS UK LIMITED

What is being bought

Published requirement description

Procurement of REVOLADE (ELTROMBOPAG) TABLETS, 28 tablet

The lotProcurement structure

single lot · no lot value published

Lot #1Awarded

Delivery: Northern Ireland

33600000 Pharmaceutical products

Procedure terms & legal framework

From the official record

Procedure method: Direct award
Legal basis: UKPGA · 2023/54 Procurement Act 2023
Notice status: Awarded without competition
Procurement threshold: Unspecified in notice
Regulatory regime: Standard
Commercial structure: Stand-alone contract (no framework)
Competition type: Direct award (no call for competition)
GPA / WTO covered: Unspecified in notice
Recurring procurement: Unspecified in notice
First published: 17 Jun 2026, 09:13 BST
Last source update: 7 Jul 2026, 09:21 BST
Authority reference: DACPM2026-42
FTS notice number: 2026/S 000-063431
Latest notice: Contract details notice (UK7)
Delivery area: Northern Ireland (UKN)
Official registry OCID: ocds-h6vhtk-06b676 Find a Tender

Why no open competition: Single Suppliers Intellectual Property Exclusive Rights
Published justification: These are branded patent protected medicines that are essential to patient care and are available from only one economic operator. The absence of competition is not a result of the artificial narrowing of the parameters of the procurement.

Notice history

4 events · 3 releases on Find a Tender · since 17 Jun 2026

Transparency notice published
17 Jun 2026, 09:13 BST
UK5
Contract award notice published
17 Jun 2026, 09:16 BST
UK6
Contract signature expected
6 Jul 2026, 23:59 BST
scheduled
Contract details notice published
7 Jul 2026, 09:21 BST
UK7

Commercial outcome & contract awards

Published awards, contracts and bid statistics, not a forecast

Awards 1

Awarded value £1,000,0001 award exc. VAT

Contracts signed 1latest 7 Jul 2026

Awarded to	Value	Date	Status
NOVARTIS PHARMACEUTICALS UK LIMITED6 Jul 2026 – 30 Jun 2028	£1,000,000	17 Jun 2026	Awarded

Contracts

REVOLADE (ELTROMBOPAG) TABLETS, 28 tablet · NOVARTIS PHARMACEUTICALS UK LIMITED
Signed
7 Jul 2026
Value
£1,000,000
Period
7 Jul 2026 – 30 Jun 2028
Status
active
No agreed KPIs: Is not more than £5 million.

Contracting authority & participating public bodies

Belfast Health & Social Care Trust

Contracting authorityPublic authority - central governmentNorthern Irish devolved regulations apply GB-PPON: PLQJ-5727-JCLR Trust Headquarters, 2nd Floor, Non Clinical Support Building, Royal Victoria Hospital, Belfast, Northern Ireland, BT12 6BAContact email

Bidders & participating suppliers

1 commercial party on the notice

NOVARTIS PHARMACEUTICALS UK LIMITEDAwarded supplierGB-COH: 00119006GB-PPON: PJTX-5182-QVLR 2nd Floor, The Westworks Building White City Place, London, London, W12 7FQContact email

Official documents & specifications (3)

Official links; attachments are not copied

Notices published for this procedure

Contract details notice contractContract details noticeUK7Contract details notice on Find a Tender7 Jul 2026, 09:21 BST
Contract award notice awardContract award noticeUK6Contract award notice on Find a Tender17 Jun 2026, 09:16 BST
Transparency notice awardTransparency noticeUK5Transparency notice on Find a Tender17 Jun 2026, 09:13 BST